ONB
AXSM icon

Old National Bancorp’s Axsome Therapeutics AXSM Stock Holding History

Old National Bancorp’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,550
Closed -$318K – 645
2023
Q3 		$318K Sell
4,550
-3,710
-45% -$277K 0.01% 472
2023
Q2 		$594K Hold
8,260
– – 0.02% 376
2023
Q1 		$509K Sell
8,260
-9,185
-53% -$603K 0.02% 404
2022
Q4 		$1.34M Sell
17,445
-9,173
-34% -$548K 0.04% 274
2022
Q3 		$1.19M Buy
26,618
+900
+3% +$45K 0.04% 281
2022
Q2 		$985K Buy
+25,718
New +$813K 0.03% 307

Other funds holding AXSM

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Old National Bancorp's AXSM Position: Q4 2023 in Review

Old National Bancorp sold out of Axsome Therapeutics (AXSM) in Q4 2023, closing a stake of 4,550 shares — an estimated $318K sold.

Old National Bancorp first reported a position in AXSM in Q2 2022 and held it in 6 quarters. The position peaked at $1.34M in Q4 2022. 244 funds tracked by Wall St. Rank hold AXSM as of Q4 2023.

  • Old National Bancorp reported no remaining Axsome Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Old National Bancorp sold 4,550 Axsome Therapeutics shares in Q4 2023, an estimated $318K.
  • Old National Bancorp first reported a position in Axsome Therapeutics in Q2 2022 and held it in 6 quarters.
  • Old National Bancorp's Axsome Therapeutics position peaked at $1.34M in Q4 2022.
  • 244 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q4 2023.

Based on Old National Bancorp's 13F filing for Q4 2023, filed 1 Feb 2024.